10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 322 filers reported holding 10X GENOMICS INC in Q1 2021. The put-call ratio across all filers is 1.39 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $490,627 | -65.9% | 11,894 | -53.8% | 0.00% | -66.7% |
| Q2 2023 | $1,437,097 | -17.3% | 25,736 | -17.4% | 0.00% | 0.0% |
| Q1 2023 | $1,738,302 | +57.6% | 31,158 | +2.9% | 0.00% | +50.0% |
| Q4 2022 | $1,103,328 | +1708.7% | 30,278 | +1290.2% | 0.00% | – |
| Q3 2022 | $61,000 | -99.6% | 2,178 | -99.4% | 0.00% | -100.0% |
| Q2 2022 | $16,038,000 | -44.3% | 354,481 | -6.4% | 0.03% | -34.0% |
| Q1 2022 | $28,808,000 | -22.2% | 378,757 | +52.4% | 0.05% | -15.3% |
| Q4 2021 | $37,032,000 | -8.3% | 248,608 | -10.4% | 0.06% | -13.2% |
| Q3 2021 | $40,402,000 | -27.1% | 277,550 | -1.9% | 0.07% | -26.9% |
| Q2 2021 | $55,422,000 | +18.5% | 283,044 | +9.5% | 0.09% | +12.0% |
| Q1 2021 | $46,776,000 | +4707.4% | 258,446 | +3665.8% | 0.08% | +4050.0% |
| Q4 2020 | $973,000 | +112.9% | 6,863 | +34.0% | 0.00% | +100.0% |
| Q2 2020 | $457,000 | +284.0% | 5,121 | +166.4% | 0.00% | – |
| Q1 2020 | $119,000 | – | 1,922 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |